Background Concurrent chemoradiotherapy (CCRT) using conventional platinum-based
doublets are often associated with significant incidence of toxic effects in elderly patients …

Background Multiple randomized controlled trials have shown that multimodal therapy
provides the best overall survival for patients who had locally advanced esophageal cancer …

Background: To evaluate the efficacy and toxicity of concurrent chemoradiation in patients
with esophageal cancer aged 75 and older. Patients and Methods: Twenty-two elderly …

Importance Palliative radiotherapy (RT) is generally recommended for older patients with
esophageal squamous cell carcinoma (ESCC) with poor prognosis. A new combination …

Results Fourteen patients were aged over 80 and 24 under 79 years. Complete treatment
compliance was obtained in 30 (78.9%) of the patients. Chemotherapy was terminated and …

Purpose: To assess the safety and efficacy of external beam radiotherapy for elderly patients
with esophageal cancer. Methods and Materials: A trial testing external beam radiotherapy …

Background The purpose of this retrospective study was to evaluate the feasibility and
efficacy of definitive concurrent chemoradiotherapy (CCRT) with capecitabine and cisplatin …

Objective The aim of this study was to review the treatment outcomes of surgery and
definitive chemoradiotherapy (CRT) in elderly patients with squamous cell carcinoma of the …

Purpose To evaluate the survival benefit of combining radiotherapy with surgery in locally
advanced esophageal squamous cell carcinoma (ESCC) patients aged over 65. Methods …

This study compared the efficiency and safety of radiotherapy plus erlotinib with concurrent
chemoradiotherapy (CCRT) based on paclitaxel plus cisplatin in elderly esophageal cancer …